Clinical study on safety and efficacy of qinin® (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4773-4776

  Zhan, Yi Ping ^a,b   Huang, Xin En ^a   Cao, Jie ^a   Lu, Yan Yan ^a   Wu, Xue Yan ^a   Liu, Jin ^a   Xu, Xia ^a   Xu, Lin ^a   Xiang, Jin ^a   Ye, Li Hong ^b  

^a JIANGSU CANCER HOSPITAL   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cantharides sodium injection; Chemotherapy; Gastric cancer treatment

Indexed keywords

EID: 84874011359     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4773     Document Type: Article

References (38)

1. Bajsa J, Pan Z, Duke SO (2011). Transcriptional responses to cantharidin, a protein phosphatase inhibitor, in Arabidopsis thaliana reveal the involvement of multiple signal transduction pathways. Physiol Plant, 143, 188-205.
2. Cui DL, Yao XX (2008). Progress in the treatment of hepatitis B and digestive tumors with cantharidin and its analogues. World Chin J Digestol, ??, 5-13.
3. De Angelis V (2004). Activity, objective response, and WHO and RECIST (Response Evaluation Criteria In Solid Tumor) evaluation criteria. Suppl Tumori, 3, S7-9.
4. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
5. Gao LL, Huang XE, Zhang Q, et al (2011). A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial. Asian Pac J Cancer Prev, 12, 77-80.
6. Gong P, Huang XE, Chen CY, et al (2012). Comparison on complications of peripherally inserted central catheters by ultrasound guide or conventional method in cancer patients. Asian Pacific J Cancer Prev, 13, 1873-5.
7. Guo S, Qi Y, Lin S, et al (2009). Systhesis of sodium cantharidinate. Strait Pharmaceutical J, ??, 01-048
8. Hsieh CH, Huang YC, Tsai TH, Chen YJ (2011) Cantharidin modulates development of human monocyte-derived dendritic cells. Toxicol In Vitro, 25, 1740-7.
9. Huang WW, Ko SW, Tsai HY, et al (2011). Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. Int J Oncol, 38, 1067-73.
10. Huang XE, Li CG, Li Y, et al (2011). Weekly TP regimen as a postoperative adjuvant chemotherapy for completely resected breast cancer in China: final result of a phase II trial. Asian Pacific J Cancer Prev, 12, 2797-800.
11. Jemal AB, Center F, et al. (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
12. Jiang Y, Huang XE, Yan PW, et al (2010). Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy. Asian Pacific J Cancer Prev, 11, 1059-62.
13. Kuo JH, Chu YL, Yang JS, et al (2010). Cantharidin induces apoptosis in human bladder cancer TSGH 8301 cells through mitochondria-dependent signal pathways. Int J Oncol, 37, 1243-50.
14. Liang F, Wang MY, Huang WB, Li AJ (2011). [Effect of sodium cantharidinate on the angiogenesis of nude mice with human gastric cancer]. Zhong Yao Cai, 34, 343-6
15. Li CG, Huang XE, Li Y (2011) Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer. Asian Pacific J Cancer Prev, 12, 487-90.
16. Li CG, Huang XE, Li Y, et al (2011). Clinical observations on safety and efficacy of OxyContin® administered by rectal route in treating cancer related pain. Asian Pac J Cancer Prev, 12, 2477-8.
17. Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients. Asian Pacific J Cancer Prev, 13, 301-4.
18. Li Y, Yan PW, Huang XE, et al (2011). MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pacific J Cancer Prev, 12, 2405-9.
19. Liu D, Chen Z (2009). The effects of cantharidin and cantharidin derivates on tumour cells. Anticancer Agents Med Chem, 9, 392-6.
20. Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from rosa roxburghii tratt and fagopyrum cymosum. Asian Pac J Cancer Prev. 13, 2409-14.
21. Okines A, Verheij M, Allum W, et al (2010). Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 50, S50-4.
22. Shu J, Li CG, Liu YC, et al (2012). Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients. Asian Pac J Cancer Prev, 13, 2399-403.
23. Sohaib A (2012). RECIST rules. Cancer Imaging, 12, 345-6.
24. Verma AK, Prasad SB(2012). Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma. Cell Biol Toxicol, 28, 133-47.
25. Wu ZM, Liu Q, Qi XH (2010). Efficacy of cantharidin combined with transcatheter arterial embolization for primary hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao, 30, 2774-6.
26. Xu HX, Huang XE, Li Y, et al (2011). A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac J Cancer Prev, 12, 2233-6.
27. Xu HX, Huang XE, Qian ZY, et al (2011). Clinical observation of Endostar® combined with chemotherapy in advanced colorectal cancer patients. Asian Pac J Cancer Prev, 12, 3087-90.
28. Xu JW, Li CG, Huang XE, et al (2011). Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases. Asian Pac J Cancer Prev, 12, 985-7.
29. Xu T, Xu ZC, Zou Q, Yu B, Huang XE (2012). P53 Arg72Pro Polymorphism and Bladder Cancer Risk - Meta- analysis Evidence for a Link in Asians but not Caucasians. Asian Pac J Cancer Prev, 13, 2349-54.
30. Xu Y, Zhao AG, Li ZY (2012). Survival Benefit of Traditional Chinese Herbal Medicine (a Herbal Formula for Invigorating Spleen) for Patients With Advanced Gastric Cancer. Integr Cancer Ther, 9, 9.
31. Yan PW, Huang XE, Jiang Y, et al (2010). A clinical comparison on safety and efficacy of Paclitaxel/Epirubicin (NE) with Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as postoperative adjuvant chemotherapy in breast cancer. Asian Pac J Cancer Prev, 11, 1115-8.
32. Yan PW, Huang XE, Yan F, et al (2011). Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. Asian Pac J Cancer Prev, 12, 2291-4.
33. Yao CY, Huang XE, Tang JH, et al (2010). Clinical observationson safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion. Asian Pac J Cancer Prev, 11, 553-5.
34. Yates JW, Chalmer B, McKegney FP (1980). Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer, 45, 2220-4.
35. Yu DS, Huang XE, Zhou JN, et al (2012). A Comparative Study on the Value of Anal Preserving Surgery for Aged People with Low Rectal Carcinoma in Jiangsu, China. Asian Pacific J Cancer Prev, 13, 2339-40.
36. Zhang LQ, Huang XE, Wang J (2011). The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a metaanalysis of 20 populations. Asian Pac J Cancer Prev, 12, 81-5.
37. Zhang XZ, Huang XE, Xu YL, et al (2012). A Phase II Study on Voriconazole in Treating Chinese Patients with Malignant Hematological Disorder and Invasive Aspergillosis. Asian Pacific J Cancer Prev, 13, 2415-8.
38. Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/ Docetaxel combined with a paltinum in the treatment of advanced non-samll cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50.